Purdue Pharma - SWOT Analysis - SWOT Analysis

Purdue Pharma - SWOT Analysis - SWOT Analysis

Datamonitor's Purdue Pharma L.P. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Purdue Pharma (Purdue), a privately held pharmaceutical company, is specialized in developing, manufacturing, and marketing sustained-release and long-acting treatments for chronic and severe pain. Its opioid drugs for pain relief include OxyContin (a controlled-release version of oxycodone) and slow-release morphine drug MS Contin. The company operates exclusively in the US. It employs about 1,300 people. As a private company, Purdue is not obligated to release its financial data.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

Table of Contents:
This product typically includes the following sections:

Key Facts
Company Overview
Business Description
Company History
Key Employees
Key Employee Biographies
Company View
SWOT analysis
Products & Services Listing
Products & Services Analysis